Stivarga - Regorafenib 40mg 28 Tablets - Anticancer Medication

Stivarga 40 mg Regorafenib Tablets

Prescription Required

Stivarga 40 mg Tablet contains Regorafenib, an oral targeted therapy used to treat certain types of cancers such as metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).

Generic Name	Regorafenib
Manufacturer	Bayer
Packing	28 Tablets in 1 Bottle
Prescribed For	Metastatic Colorectal Cancer, GIST, and Hepatocellular Carcinoma
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of Stivarga 40 mg

Helps slow the spread of cancer cells
Supports comprehensive cancer treatment
Used as a targeted therapy medicine
May help manage tumor progression
Supports advanced oncology care
Helps improve quality of life

Side Effects

Fatigue or weakness
Loss of appetite
Diarrhea
Weight loss
High blood pressure (hypertension)
Voice changes (hoarseness)
Hand-foot skin reaction (redness, pain, or peeling on palms and soles)
Nausea or vomiting
Abdominal pain

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.